UMB Bank’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-244
Closed -$1.94K – 2179
2025
Q1
$1.94K Sell
244
-181
-43% -$1.83K ﹤0.01% 1973
2024
Q4
$3.86K Buy
425
+325
+325% +$3.14K ﹤0.01% 1797
2024
Q3
$918 Sell
100
-309
-76% -$2.56K ﹤0.01% 2072
2024
Q2
$4K Buy
409
+309
+309% +$3.77K ﹤0.01% 1513
2024
Q1
$1.51K Sell
100
-706
-88% -$12.8K ﹤0.01% 1620
2023
Q4
$17.4K Buy
806
+528
+190% +$9.74K ﹤0.01% 1109
2023
Q3
$5.17K Hold
278
– – ﹤0.01% 1417
2023
Q2
$7.04K Hold
278
– – ﹤0.01% 1369
2023
Q1
$7.2K Sell
278
-40
-13% -$1.07K ﹤0.01% 1360
2022
Q4
$8K Sell
318
-329
-51% -$8.87K ﹤0.01% 1366
2022
Q3
$16K Buy
647
+274
+73% +$9.61K ﹤0.01% 1186
2022
Q2
$12K Sell
373
-758
-67% -$32.2K ﹤0.01% 1342
2022
Q1
$82K Buy
1,131
+286
+34% +$20.6K ﹤0.01% 815
2021
Q4
$77K Buy
+845
New +$101K ﹤0.01% 859

Other funds holding TDOC

UMB Bank's TDOC Position: Q2 2025 in Review

UMB Bank sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 244 shares — an estimated $1.94K sold.

UMB Bank first reported a position in TDOC in Q4 2021 and held it in 14 quarters. The position peaked at $82K in Q1 2022. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • UMB Bank reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • UMB Bank sold 244 Teladoc Health shares in Q2 2025, an estimated $1.94K.
  • UMB Bank first reported a position in Teladoc Health in Q4 2021 and held it in 14 quarters.
  • UMB Bank's Teladoc Health position peaked at $82K in Q1 2022.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on UMB Bank's 13F filing for Q2 2025, filed 10 Jul 2025.